BEUDAMED
    FDA Adverse Event Injury Summary report: N

    DEKA SYNCHRO REPLAY EXCELLIUM 3.4

    MDR report key: 6105783 · Received November 16, 2016

    Report

    Report Number
    3001431138-2016-00010
    Event Type
    Injury
    Date Received
    November 16, 2016
    Date of Event
    October 18, 2016
    Report Date
    November 16, 2016
    Manufacturer
    EL.EN. ELECTRONIC ENGINEERING S.P.A.
    Product Code
    GEX
    UDI-DI
    08057017760108
    PMA / PMN Number
    K150516
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    IT
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 1

    THE DEKA SYNCHRO REPLAY EXCELLIUM 3.4 DEVICE IS EQUIPPED WITH A SPECIFIC BUILT-IN MEASURING SYSTEM IN ORDER TO DETERMINE THE EFFICIENCY OF BOTH LASER AND FT HANDPIECES. THE SYSTEM AUTOMATICALLY REQUIRES, EVERY TIME THAT THE FT HANDPIECE IS SELECTED, TO PERFORM THE TEST OF THE HANDPIECE. IF THE EFFICIENCY IS OUTSIDE THE 20% NEIGHBORHOOD OF THE SET VALUE, A WARNING MESSAGE APPEARS ASKING TO PERFORM THE TEST AGAIN. IF THE VALUE IS STILL OUTSIDE THE 20% NEIGHBORHOOD OF THE SET VALUE THE SYSTEMS WARNS THE USER BY DISPLAYING THE EFFICIENCY READING AND A CLAIM TO CONTACT TECHNICAL SERVICE FOR FT HANDPIECE CHECK. BY COMING BACK TO THE PARAMETER'S PAGE IT WILL SCREEN A GENERAL CAUTION SYMBOL BESIDE THE NEW FLUENCY PARAMETER (CALCULATED ON THE BASIS OF THE ACTUAL EFFICIENCY'S READING AND VISUALIZED IN RED COMPARED WITH THE INITIAL FLUENCY VALUE SET BY THE USER). THE USER, IN THIS CASE, PRIOR TO THE USAGE OF THE FT HANDPIECE, HAVE GOT AN EFFICIENCY READING OF 122% AS RECORDED IN THE SYSTEM'S LOG. THE SYSTEM WARNED THE USER TO CALL SERVICE AND DISPLAYED THE EFFECTIVE FLUENCY RELATED TO THE EFFICIENCY READING. THIS DOUBLE-CHECK IS NOT AVOIDABLE AND ITS WARNING COULD NOT GO UNDETECTED. DESPITE THE WARNING THE OPERATOR VOLUNTARILY AND CONSCIOUS CONTINUED THE USAGE OF THE DEVICE PERFORMING FT TREATMENT AT HIGHER VALUES. THIS TESTING ROUTINE AND ITS WARNINGS HAVE BEEN VERIFIED IN DEPTH CONFIRMING THAT IT WORKS AS INTENDED AS DOCUMENTED IN THE INTERNAL REPORT CODE (B)(4). THE ACTUAL DEVICE WAS NOT RETURNED TO THE MANUFACTURER'S PLANT FOR EVALUATION. MANUFACTURER'S SERVICE PERSONNEL CHECKED THE ACTUAL SUSPECTED DEVICE UNIT AT CUSTOMER SITE ON OCTOBER 20TH, 2016. (B)(4) SERVICE PERSONNEL EVALUATED THE DEVICE FOR CALIBRATION AND PERFORMANCE OF LASER AND ACCESSORIES. THE DEKA SYNCHRO REPLAY EXCELLIUM 3.4 UNIT AND RELEVANT ACCESSORIES WERE DETERMINED TO BE OPERATING PROPERLY WITHIN THEIR SPECIFICATIONS. NO FAILURE DETECTED ((B)(4)). THE INVESTIGATION CARRIED OUT DID NOT CONCLUDE THAT A DESIGN DEFICIENCY OR DEVICE MALFUNCTIONING WAS RESPONSIBLE FOR CAUSING THE EVENT. RATHER, IT COULD BE ASSUMED THAT THERE WAS A HUMAN FACTORS ISSUE, WHERE A FAILURE TO PROPERLY USE THE DEVICE ACCORDING TO INSTRUCTION FOR USE AND WARNINGS, CONTRIBUTED TO THE EVENT. CONCERNING THE NATURE OF THE PATIENT'S INJURY, THE OPERATOR MANUAL CODE OM104F1-G1-H1-I1_I.V13 (ACTUAL REVISION SHIPPED WITH THE DEVICE) IN SECTION 9.2 'ADVERSE EFFECTS', REPORTS THAT BLISTERING AND SCARRING ARE FORSEEABLE SIDE EFFECTS OF THE TREATMENT. BLISTERING AND SCARRING CAN BE MEANT AS AN EXPECTED EVOLUTION OF A BURN. MOREOVER THOSE SIDE EFFECTS ARE CONSIDERED AND EVALUATED IN THE RISK ANALYSIS. NO FAILURE DETECTED IN THE ACTUAL DEVICE EVALUATED. DEVICE WORKING WITHIN SPECS. BASED ON THAT, NO REMEDIAL ACTIONS ARE REQUIRED. THIS INITIAL REPORT IS TO BE CONSIDERED AS FINAL REPORT, UNLESS FDA HAS FURTHER QUESTIONS.

    Description of Event or Problem · 1

    (B)(4) SALES AGENT FOR (B)(6) MR. (B)(6) NOTICED US ABOUT AN ADVERSE EVENT HE RECENTLY BECAME AWARE OF. INVOLVED DEVICE IS DEKA SYNCHRO REPLAY EXCELLIUM 3.4 MODEL NUMBER M104H1, S/N (B)(4), MANUFACTURED BY (B)(4). THE ACTUAL DATE OF THE EVENT IS UNKNOWN (BEST ESTIMATE DATE OF THE EVENT (B)(6) 2016) AND (B)(4) BECAME AWARE OF THE EVENT ON (B)(6) 2016. EVENT TOOK PLACE IN THE (B)(6). OUR SERVICE TECHNICIAN VISITED THE CUSTOMER AND INFORMED US THAT ONE DEKA SYNCHRO REPLAY EXCELLIUM 3.4 WAS INVOLVED IN A LASER TREATMENT FOR FACE BENIGN PIGMENTATED LESIONS (DARK SPOT ON CHEEK) ON PATIENT WHO DEVELOPED A BURN ON CHEEK. WE, THE MANUFACTURER OF THE DEVICE DEKA SYNCHRO REPLAY EXCELLIUM 3.4 MARKETED IN THE US TERRITORY, ACCORDING TO 21 CFR 803.50 SUBMITTED TO FDA AN OWN INITIAL 30 DAYS MDR REPORT. THIS EVENT IS REPORTED TO FDA IN THE SIDE ORF CAUTION DUE TO THE FACT THAT WE DID NOT HAVE ANY INFORMATION CONCERNING THE STATE OF HEALING OF THE PATIENT AT THE TIME AND THAN WE CONSIDER THE BURN AS A POTENTIAL EVOLVING TO A PERMANENT DAMAGE.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    757658 DEKA SYNCHRO REPLAY EXCELLIUM 3.4 DEKA SYNCHRO REPLAY EXCELLIUM 3.4 GEX EL.EN. ELECTRONIC ENGINEERING S.P.A. M104H1 08057017760108

    Patients

    Seq Age Sex Outcome Treatment
    1 Other